About 20/20 Biolabs Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://2020gene.com/
Analyst Recommendation Trends
Wall Street analyst consensus for AIDX over the last few months:
Latest AIDX News
20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026
Management to Hold One-on-One Meetings with Institutional Investors at the Hard Rock Hotel New York GAITHERSBURG, Md., Oct. 02, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX) (the “Company”), an early market entrant in AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that President and Chief Executive Officer Jonathan Cohen and Chief Financial Officer Alan Bergman will participate in the Maxim Growth Sum
20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model
President and CEO Jonathan Cohen to Discuss Implications for Multi-Cancer Early Detection, Preliminary Interest from Laboratories Across the United States, and New State Funding for Firefighter Cancer Screening Webinar to Be Held Wednesday, October 7, 2026 at 12:00 p.m. Eastern Time; Registration Is Now Open GAITHERSBURG, Md., Sept. 29, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX) (“20/20 BioLabs” or the “Company”), an early market entrant in AI-powered, laboratory-based blood tes
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Onconetix (NASDAQ:ONCO) stock increased by 10.3% to $1.14 during Friday's after-market session. The market value of their outstanding shares is at $3.9 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch
Canada’s Ivey PMI recently hit a multi year high, hinting that businesses are spending again on tools that cut costs and raise productivity. That backdrop puts artificial intelligence in healthcare on many watchlists. AI can help Canadian hospitals and drug developers do more with limited budgets. This article walks through three AI focused healthcare stocks from our screener that could interest investors watching this shift. The stocks below are just a sample from this theme, and the full...
Healwell AI (TSX:AIDX) Stock Draws Fresh Price Target Split After Quarterly Results
Price targets for Healwell AI have been adjusted within a CA$1.50 to CA$2.00 range, with some analysts moving up to CA$2.00 and others trimming down to CA$1.50. This split reflects different views on how recent quarterly execution lines up with what investors should be willing to pay for the stock today. As you read on, you will see how to interpret these shifting targets and track the evolving narrative around Healwell AI for your own decision making. Analyst Price Targets don't always...
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-04-02 | Bergman Alan B. | +100,000 | - | - |
| 2026-04-02 | Zhou Jiming | +150,000 | - | - |